{"transactions":[{"id":1387115,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":86797,"kind":"person","name":"Valencia Catalina","position":1,"cik":"0001944813","reported_name":"Valencia Catalina","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and Director"}}],"security":"Common Stock","published_at":"2024-10-15T17:05:08.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":1086216,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired from third party"}],"balance_after":28608220,"source":{"system":"sec-edgar","filing":"0001096906-24-002004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944813/000109690624002004/form4.xml","form_type":"4"}},{"id":1569511,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":25903,"kind":"person","name":"O'Rourke Peter","position":1,"cik":"0001890749","reported_name":"O'Rourke Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2024-03-19T23:24:23.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":35000,"value":1225000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a convertible note, face value $35,000.  The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share."}],"balance_after":4500000,"derivative":{"exercise_price":0.01,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000515","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890749/000109690624000515/form4.xml","form_type":"4"}},{"id":1567664,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Note","published_at":"2024-03-19T19:59:06.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":250000,"value":62500000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reporting Person acquired a convertible note, face value $250,000.  The note is convertible into shares of Issuer's common stock at a price of $0.02 per share."}],"balance_after":42500000,"derivative":{"exercise_price":0.02,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":12500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000525","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000525/form4.xml","form_type":"4/A","original_submission_date":"2024-03-19"}},{"id":1567663,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Note","published_at":"2024-03-19T19:59:06.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":250000,"value":62500000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired an Amended Convertible Promissory Note in the face amount of $250,000.  The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share."}],"balance_after":30000000,"derivative":{"exercise_price":0.01,"exercise_date":"2026-01-23","expiration_date":"2033-01-24","underlying":"Common Stock","underlying_shares":25000000},"source":{"system":"sec-edgar","filing":"0001096906-24-000525","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000525/form4.xml","form_type":"4/A","original_submission_date":"2024-03-19"}},{"id":1570578,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":86797,"kind":"person","name":"Valencia Catalina","position":1,"cik":"0001944813","reported_name":"Valencia Catalina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2024-03-19T19:39:54.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":7837500,"price":156750,"value":1228528125000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a convertible note, face value $156,750.  The note is convertible into shares of the Issuer's common stock at a price of $0.02 per share for conversion into a total of 7,837,500 shares.."}],"balance_after":7837500,"derivative":{"exercise_price":0.02,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":7837500},"source":{"system":"sec-edgar","filing":"0001096906-24-000524","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944813/000109690624000524/form4.xml","form_type":"4"}},{"id":1567662,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2024-03-19T19:37:27.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":35000,"value":1225000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a convertible note, face value $35,000.  The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share."}],"balance_after":4500000,"derivative":{"exercise_price":0.01,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000522/form4.xml","form_type":"4"}},{"id":1567660,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92866,"kind":"person","name":"Cunningham Robert L","position":1,"cik":"0001708731","reported_name":"Cunningham Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2024-03-19T19:33:59.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":35000,"value":1225000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a Convertible Note, face value $35,000.  The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share."}],"balance_after":4500000,"derivative":{"exercise_price":0.01,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000520","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000520/form4.xml","form_type":"4"}},{"id":1567661,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92867,"kind":"person","name":"Scott Timothy Richard","position":1,"cik":"0001709014","reported_name":"Scott Timothy Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2024-03-19T19:29:06.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":35000,"value":1225000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a convertible note, face value $35,000.  The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share."}],"balance_after":4500000,"derivative":{"exercise_price":0.01,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000517/form4.xml","form_type":"4"}},{"id":1568541,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Convertible Note","published_at":"2024-03-19T19:16:08.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":53500,"price":53500,"value":2862250000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a Convertible Note face $53,500.  The Note is convertible into shares of the Issuers common stock at a price of $0.02 per share."}],"balance_after":3475000,"derivative":{"exercise_price":0.02,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":2675000},"source":{"system":"sec-edgar","filing":"0001096906-24-000511","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000109690624000511/form4.xml","form_type":"4"}},{"id":1567659,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Note","published_at":"2024-03-19T19:14:19.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":1,"price":250000,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a convertible note, face value $250,000.  The note is convertible into shares of Issuer's common stock at a price of $0.02 per share."}],"balance_after":42500000,"derivative":{"exercise_price":0.02,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":12500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000509/form4.xml","form_type":"4"}},{"id":2151783,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-09-23T18:06:08.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date."}],"balance_after":1000000,"derivative":{"exercise_price":0.052,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002340/form4.xml","form_type":"4"}},{"id":2151972,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option","published_at":"2022-09-23T16:33:29.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired an option to purchase up to 500,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date."}],"balance_after":800000,"derivative":{"exercise_price":0.052,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001096906-22-002337","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000109690622002337/form4.xml","form_type":"4"}},{"id":2151971,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option","published_at":"2022-09-23T16:31:32.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":300000,"derivative":{"exercise_price":0.42,"exercise_date":"2020-12-10","expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001096906-22-002336","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000109690622002336/form4.xml","form_type":"4"}},{"id":2151781,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92866,"kind":"person","name":"Cunningham Robert L","position":1,"cik":"0001708731","reported_name":"Cunningham Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-09-23T16:29:31.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date."}],"balance_after":1500000,"derivative":{"exercise_price":0.052,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002335","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002335/form4.xml","form_type":"4"}},{"id":2151782,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92866,"kind":"person","name":"Cunningham Robert L","position":1,"cik":"0001708731","reported_name":"Cunningham Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-09-23T16:27:28.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired the option to purchase 500,000 shares of Issuer's common stock (\"Option Shares\") on May 13, 2020 (the \"Date of Grant\").  One-third of the Option Shares will vest on the Date of Grant; (iii) one-third of the Option Shares will vest six (6) months from the Date of Grant; and (iv) the remaining one-third of the Option Shares shall vest twelve (12) Months from the Date of Grant, provided, however, that there has not been a Termination of Service as of such date.  In no event shall the Option become exercisable for any additional Option Shares after a Termination of Service."}],"balance_after":500000,"derivative":{"exercise_price":0.0126,"expiration_date":"2030-03-13","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001096906-22-002334","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002334/form4.xml","form_type":"4"}},{"id":2151780,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92867,"kind":"person","name":"Scott Timothy Richard","position":1,"cik":"0001709014","reported_name":"Scott Timothy Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-09-23T16:25:05.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date."}],"balance_after":1500000,"derivative":{"exercise_price":0.052,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002333","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002333/form4.xml","form_type":"4"}},{"id":2151779,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92867,"kind":"person","name":"Scott Timothy Richard","position":1,"cik":"0001709014","reported_name":"Scott Timothy Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-09-23T16:22:13.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired the option to purchase 500,000 shares of Issuer's common stock (\"Option Shares\") on May 13, 2020 (the \"Date of Grant\").  One-third of the Option Shares will vest on the Date of Grant; (iii) one-third of the Option Shares will vest six (6) months from the Date of Grant; and (iv) the remaining one-third of Option Shares shall vest twelve (12) Months from the Date of Grant, provided, however, that there has not been a Termination of Service as of such date.  In no event shall the Option become exercisable for any additional Option Shares after a Termination of Service."}],"balance_after":500000,"derivative":{"exercise_price":0.0126,"expiration_date":"2030-03-13","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001096906-22-002332","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002332/form4.xml","form_type":"4"}},{"id":2151777,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option","published_at":"2022-09-23T16:20:06.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired an option to purchase up to 5,000,000 shares of common stock.  50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date."}],"balance_after":8000000,"derivative":{"exercise_price":0.052,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002331","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002331/form4.xml","form_type":"4"}},{"id":2151776,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option","published_at":"2022-09-23T16:17:52.000Z","date":"2021-05-06","kind":"disposition_to_issuer","acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 6, 2021, Reporting Person voluntarily agreed to cancel the option to purchase 2,000,000 shares of the Issuer's common stock granted to Reporting Person on January 2, 2019."}],"balance_after":3000000,"derivative":{"exercise_price":0.75,"exercise_date":"2019-01-02","expiration_date":"2039-01-01","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002330","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002330/form4.xml","form_type":"4"}},{"id":2151778,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option","published_at":"2022-09-23T16:16:05.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000000,"derivative":{"exercise_price":0.42,"exercise_date":"2020-12-10","expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002329","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002329/form4.xml","form_type":"4"}},{"id":2151775,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-23T16:14:02.000Z","date":"2020-03-19","kind":"purchase","acquired":true,"shares":6000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person acquired the shares pursuant to a share exchange with the Issuer whereby Reporting Person exchanged 100% of the Sapphire Biotech, Inc. shares common stock held by Reporting Person for 6,000,000 shares of common stock of the Issuer."}],"balance_after":6000000,"source":{"system":"sec-edgar","filing":"0001096906-22-002328","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002328/form4.xml","form_type":"4"}},{"id":2151774,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option","published_at":"2022-09-23T16:11:26.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 2, 2019, Reporting Person acquired an option to purchase up to 2,000,000 shares of common stock.  50% of the shares may be purchased immediately and the remaining 50% of the shares may be purchased at the date which is six (6) months following the grant date."}],"balance_after":2000000,"derivative":{"exercise_price":0.75,"expiration_date":"2039-01-01","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002327","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002327/form4.xml","form_type":"4"}},{"id":2170254,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":86797,"kind":"person","name":"Valencia Catalina","position":1,"cik":"0001944813","reported_name":"Valencia Catalina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-31T16:01:16.000Z","date":"2022-08-24","kind":"purchase","acquired":true,"shares":3861004,"price":0.0259,"value":100000.0036,"ownership":{"direct":true},"balance_after":23661004,"source":{"system":"sec-edgar","filing":"0001096906-22-002075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944813/000109690622002075/form4.xml","form_type":"4"}},{"id":2172665,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T17:05:16.000Z","date":"2022-08-22","kind":"exercise","acquired":true,"shares":854012,"price":0.029,"value":24766.348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Conversion of Note"}],"balance_after":854012,"source":{"system":"sec-edgar","filing":"0001096906-22-002027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002027/form4.xml","form_type":"4"}},{"id":2394041,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92868,"kind":"person","name":"Schroeder Blake","position":1,"cik":"0001708685","reported_name":"Schroeder Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note (Convertible into Common Stock)","published_at":"2022-02-15T18:04:17.000Z","date":"2022-02-10","kind":"other","acquired":true,"shares":25000,"price":25000,"value":625000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Note bears interest at a rate of 3% per annum.  At the election of the Reporting Person, all principal and accrued interest under the  Note may be converted into the Issuer's common stock at a converstion price equal to the lesser of $0.08125 or 70% of the average of the two lowest closing prices of the Issuer's common stock in the ten (10) days prior to the date of conversion."}],"balance_after":307692,"derivative":{"exercise_price":0.0812,"exercise_date":"2022-02-10","expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":307692},"source":{"system":"sec-edgar","filing":"0001096906-22-000339","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000339/form4.xml","form_type":"4"}},{"id":3967681,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92881,"kind":"person","name":"MALASEK ROBERT","position":1,"cik":"0001493185","reported_name":"MALASEK ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2018-04-06T15:35:47.000Z","date":"2018-03-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001078782-18-000415","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493185/000107878218000415/primary_doc.xml","form_type":"4"}},{"id":4417833,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":163449,"kind":"organization","name":"Medical Marijuana Inc","position":1,"cik":"0001604964","reported_name":"Medical Marijuana Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Stock","published_at":"2017-02-28T19:11:31.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reporting person holds 500,000 shares of Series C Preferred Stock."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001078782-17-000274","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604964/000107878217000274/primary_doc.xml","form_type":"5/A","original_submission_date":"2017-02-15"}},{"id":4417832,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":163449,"kind":"organization","name":"Medical Marijuana Inc","position":1,"cik":"0001604964","reported_name":"Medical Marijuana Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-28T19:11:31.000Z","date":"2016-12-02","kind":"grant","acquired":true,"shares":7200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Reporting person is the owner of MJNA Investment Holdings, LLC which holds 17,969,125 shares of common stock."}],"balance_after":22669125,"source":{"system":"sec-edgar","filing":"0001078782-17-000274","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604964/000107878217000274/primary_doc.xml","form_type":"5/A","original_submission_date":"2017-02-15"}},{"id":4445780,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":163449,"kind":"organization","name":"Medical Marijuana Inc","position":1,"cik":"0001604964","reported_name":"Medical Marijuana Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Stock","published_at":"2017-02-15T21:01:02.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Reporting person holds 500,000 shares of Series C Preferred Stock."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001078782-17-000218","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604964/000107878217000218/primary_doc.xml","form_type":"5"}},{"id":4445779,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":163449,"kind":"organization","name":"Medical Marijuana Inc","position":1,"cik":"0001604964","reported_name":"Medical Marijuana Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-15T21:01:02.000Z","date":"2016-12-02","kind":"grant","acquired":true,"shares":7200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Reporting person is the owner of MJNA Investment Holdings, LLC which holds 17,443,650 shares of common stock."}],"balance_after":22143650,"source":{"system":"sec-edgar","filing":"0001078782-17-000218","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604964/000107878217000218/primary_doc.xml","form_type":"5"}},{"id":4445719,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":107714,"kind":"person","name":"Changoer Lekhram","position":1,"cik":"0001604389","reported_name":"Changoer Lekhram","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Stock","published_at":"2017-02-15T19:34:01.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote 2"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 500,000 shares of Series B Preferred Stock."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001078782-17-000217","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604389/000107878217000217/primary_doc.xml","form_type":"5"}},{"id":4445718,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":107714,"kind":"person","name":"Changoer Lekhram","position":1,"cik":"0001604389","reported_name":"Changoer Lekhram","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-15T19:34:01.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Changoer is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock."}],"balance_after":2265000,"source":{"system":"sec-edgar","filing":"0001078782-17-000217","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604389/000107878217000217/primary_doc.xml","form_type":"5"}},{"id":4445717,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":107714,"kind":"person","name":"Changoer Lekhram","position":1,"cik":"0001604389","reported_name":"Changoer Lekhram","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-15T19:34:01.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Changoer is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock."}],"balance_after":2265000,"source":{"system":"sec-edgar","filing":"0001078782-17-000217","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604389/000107878217000217/primary_doc.xml","form_type":"5"}},{"id":4445722,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":73122,"kind":"person","name":"Anastassov George","position":1,"cik":"0001604392","reported_name":"Anastassov George","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO/Secretary"}}],"security":"Preferred Stock","published_at":"2017-02-15T19:20:00.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote 2"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Mr. Anastassov is an affiliate and control person of Sanammad Foundation which holds 500,000 shares of Series B preferred stock."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001078782-17-000216","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604392/000107878217000216/primary_doc.xml","form_type":"5"}},{"id":4445721,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":73122,"kind":"person","name":"Anastassov George","position":1,"cik":"0001604392","reported_name":"Anastassov George","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO/Secretary"}}],"security":"Common Stock","published_at":"2017-02-15T19:20:00.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Mr. Anastassov is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Anastassov is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock."}],"balance_after":3002000,"source":{"system":"sec-edgar","filing":"0001078782-17-000216","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604392/000107878217000216/primary_doc.xml","form_type":"5"}},{"id":4445720,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":73122,"kind":"person","name":"Anastassov George","position":1,"cik":"0001604392","reported_name":"Anastassov George","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO/Secretary"}}],"security":"Common Stock","published_at":"2017-02-15T19:20:00.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Mr. Anastassov is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Anastassov is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock."}],"balance_after":3002000,"source":{"system":"sec-edgar","filing":"0001078782-17-000216","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604392/000107878217000216/primary_doc.xml","form_type":"5"}}]}